Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma

Saved in:
Bibliographic Details
Published inClinical endocrinology (Oxford) Vol. 55; no. 3; pp. 421 - 422
Main Authors Smit, Jan W. A., Van Tol, Karin M., Hew, Joffre M., Vielvoye, G. Jan, Romijn, Johannes A., Links, Thera P.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.09.2001
Blackwell
Subjects
Adult
Aged
Antineoplastic agents
Biological and medical sciences
Bone Neoplasms - secondary
Bone Neoplasms - therapy
Chemotherapy, Adjuvant
Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
Embolization, Therapeutic
Enzyme Inhibitors - therapeutic use
Female
Humans
Hydroxamic Acids - therapeutic use
Male
Medical sciences
Metalloendopeptidases - antagonists & inhibitors
Middle Aged
Pharmacology. Drug treatments
Thyroid Neoplasms
Endocrinopathy
Human
Antineoplastic agent
Carcinoma
Treatment efficiency
Thyroid diseases
Diseases of the osteoarticular system
Adjuvant treatment
Instrumentation therapy
Thyroid gland
Malignant tumor
Metastasis
Chemotherapy
Marimastat
Adult
Embolization
Bone
Elderly
Online AccessGet full text

Cover

More Information
Bibliography:istex:71D2BA01854F6F5EB5AC1E400DC2EDF2C15C72C8
ark:/67375/WNG-3BDCT0C8-5
ArticleID:CEN1337
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-0664
1365-2265
DOI:10.1046/j.1365-2265.2001.01337.x